Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy-Reference-Cited by-同舟云学术

Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

Published:2021-03-30 Issue: Volume: Page:
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Maturi Raj K.¹,Glassman Adam R.²,Josic Kristin²,Antoszyk Andrew N.³,Blodi Barbara A.⁴,Jampol Lee M.⁵,Marcus Dennis M.⁶,Martin Daniel F.⁷,Melia Michele²,Salehi-Had Hani⁸,Stockdale Cynthia R.²,Punjabi Omar S.³,Sun Jennifer K.⁹,

Affiliation:

1. Midwest Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis

2. Jaeb Center for Health Research, Tampa, Florida

3. Charlotte Eye Ear Nose and Throat Associates, PA, Charlotte, North Carolina

4. Department of Ophthalmology and Visual Sciences, University of Wisconsin–Madison, Madison

5. Feinberg School of Medicine, Northwestern University, Chicago, Illinois

6. Southeast Retina Center, PC, Augusta, Georgia

7. Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio

8. Retina Associates of Southern California, Huntington Beach

9. Joslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts

Publisher

American Medical Association (AMA)